JP2019505493A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019505493A5 JP2019505493A5 JP2018531186A JP2018531186A JP2019505493A5 JP 2019505493 A5 JP2019505493 A5 JP 2019505493A5 JP 2018531186 A JP2018531186 A JP 2018531186A JP 2018531186 A JP2018531186 A JP 2018531186A JP 2019505493 A5 JP2019505493 A5 JP 2019505493A5
- Authority
- JP
- Japan
- Prior art keywords
- combination
- peg
- trough concentration
- serum trough
- day
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662275127P | 2016-01-05 | 2016-01-05 | |
| US62/275,127 | 2016-01-05 | ||
| PCT/US2016/068945 WO2017120081A1 (en) | 2016-01-05 | 2016-12-28 | Methods of using interleukin-10 for treating diseases and disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019505493A JP2019505493A (ja) | 2019-02-28 |
| JP2019505493A5 true JP2019505493A5 (https=) | 2020-02-13 |
Family
ID=59274328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018531186A Withdrawn JP2019505493A (ja) | 2016-01-05 | 2016-12-28 | 疾患及び障害を治療するためにインターロイキン１０を使用する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20180369337A1 (https=) |
| EP (1) | EP3400067A4 (https=) |
| JP (1) | JP2019505493A (https=) |
| KR (1) | KR20180100133A (https=) |
| CN (1) | CN108430583A (https=) |
| AU (1) | AU2016385474A1 (https=) |
| CA (1) | CA3008284A1 (https=) |
| MX (1) | MX2018007426A (https=) |
| WO (1) | WO2017120081A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7052686B2 (en) * | 2000-09-29 | 2006-05-30 | Schering Corporation | Pegylated interleukin-10 |
| US20040009146A1 (en) * | 2002-02-26 | 2004-01-15 | Osvaldo Podhajcer | Anti-tumor vaccine and method |
| CA2664304C (en) * | 2006-09-28 | 2017-08-22 | Schering Corporation | Use of pegylated il-10 to treat cancer |
| EP2986306A4 (en) * | 2013-04-18 | 2016-12-07 | Armo Biosciences Inc | METHOD FOR USE OF INTERLEUKIN-10 FOR THE TREATMENT OF ILLNESSES AND SUFFERING |
-
2016
- 2016-12-28 CA CA3008284A patent/CA3008284A1/en not_active Abandoned
- 2016-12-28 US US16/061,583 patent/US20180369337A1/en not_active Abandoned
- 2016-12-28 EP EP16884214.4A patent/EP3400067A4/en not_active Withdrawn
- 2016-12-28 MX MX2018007426A patent/MX2018007426A/es unknown
- 2016-12-28 WO PCT/US2016/068945 patent/WO2017120081A1/en not_active Ceased
- 2016-12-28 AU AU2016385474A patent/AU2016385474A1/en not_active Abandoned
- 2016-12-28 JP JP2018531186A patent/JP2019505493A/ja not_active Withdrawn
- 2016-12-28 KR KR1020187019681A patent/KR20180100133A/ko not_active Withdrawn
- 2016-12-28 CN CN201680077588.8A patent/CN108430583A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012532185A5 (https=) | ||
| JP2019077723A (ja) | 抗ＣＴＬＡ−４抗体又は抗ＰＤ−１抗体との併用におけるＩＬ−２Ｒβ選択的作動薬 | |
| JP2021505661A5 (https=) | ||
| KR101848131B1 (ko) | 저용량 이리노테칸염산염 수화물을 함유하는 항종양제 | |
| JP2017533201A5 (https=) | ||
| JP2016514132A5 (https=) | ||
| JP2018530525A5 (https=) | ||
| US8710095B2 (en) | Drugs for prophylaxis or mitigation of taxane-induced neurotoxicity | |
| CN109528731B (zh) | 具有协同作用治疗多发性骨髓瘤的药物组合物及其应用 | |
| JP5881782B2 (ja) | 医薬組成物又は組合せ剤 | |
| JP2019505493A5 (https=) | ||
| WO2020092650A1 (en) | Compositions and methods for modulating t cell exhaustion | |
| JP7412576B2 (ja) | 腎がんの相乗的治療におけるペグインターフェロンおよびプロトオンコジーン産物標的阻害剤の適用 | |
| EP2826482A1 (en) | Novel antitumor agent comprising combination of three agents | |
| JP6987271B2 (ja) | 新規キノカルコン化合物、及びがん又は炎症を治療するためのその用途 | |
| WO2006122431A1 (en) | Triazine compounds and compositions thereof for the treatment of cancers | |
| JP3064815B2 (ja) | ミエローマ系腫瘍抗癌剤 | |
| TW200740440A (en) | Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient | |
| CN112915101A (zh) | 一种抗肿瘤联合药物组合物及其应用 | |
| CN112533605A (zh) | 用于治疗癌症的组合疗法 | |
| TWI727858B (zh) | 維奈托克(venetoclax)之水溶性高分子衍生物 | |
| EP1465617B1 (en) | Process for affecting neurologic progression | |
| NZ774138A (en) | Medicament for mitigating conditions and/or suppressing onset of peripheral neuropathy induced by anti-malignant tumor agent | |
| HK40040825A (zh) | 用於治疗癌症的组合疗法 | |
| NZ774138B2 (en) | Medicament for mitigating conditions and/or suppressing onset of peripheral neuropathy induced by anti-malignant tumor agent |